Frontiers in Pediatrics (Oct 2023)
Editorial: Immunotherapy for hematological malignancies in children
- Yusi Zhou,
- Yusi Zhou,
- Yusi Zhou,
- Yang Su,
- Yang Su,
- Yang Su,
- Yutong Xu,
- Yutong Xu,
- Yutong Xu,
- Ming Shi,
- Ming Shi,
- Ming Shi
Affiliations
- Yusi Zhou
- Cancer Institute, Xuzhou Medical University, Xuzhou, China
- Yusi Zhou
- Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
- Yusi Zhou
- Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, China
- Yang Su
- Cancer Institute, Xuzhou Medical University, Xuzhou, China
- Yang Su
- Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
- Yang Su
- Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, China
- Yutong Xu
- Cancer Institute, Xuzhou Medical University, Xuzhou, China
- Yutong Xu
- Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
- Yutong Xu
- Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, China
- Ming Shi
- Cancer Institute, Xuzhou Medical University, Xuzhou, China
- Ming Shi
- Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
- Ming Shi
- Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, China
- DOI
- https://doi.org/10.3389/fped.2023.1315218
- Journal volume & issue
-
Vol. 11
Abstract
No abstracts available.Keywords
